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Initial Evaluation, Times to Intervention, In-Hospital TreTable 1 Initial Evaluation, Times to Intervention, I
H
(n
Initial evaluation and times to intervention
Symptom onset to hospital arrival, h 2.0
Ambulance use
Pre-hospital ECG
Arrival to ECG, min 8
Arrival to ECG 10 min
Door to balloon, min 74
Door to balloon 90 min
In-hospital treatment during first 24 h
Diagnostic catheterization
Reperfusion therapy
Primary PCI
Drug-eluting stent
Discharge care
Smoking cessation counseling
Diet counseling
Exercise counseling
Cardiac rehabilitation referral
Values are mean (range) or %.
ECG  electrocardiogram; PCI  percutaneous coronary interventiointracardiac ischemia detection device for continuous surveillance
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Letter to the EditorIntracardiac Electrogram
and Ischemia Alert
In an elegant study, Fischell et al. (1) employed an implantablefor ST-segmental shifts as a warning system. During a median
follow-up of 1.5 years, shifts exceeding 3 SDs were an accurate marker
for thrombotic coronary occlusion, allowing for a median alert-to-
door time of 20 min for patients at high risk of recurrent coronary
yndromes who typically present with 2- to 3-h delays. The feasibilityatmen-Hos
ispan
 1,6
(1.0–
41.5%
32.8%
(4–1
61.2%
(55–
69.4%
89.1%
91.5%
81.6%
47.9%
96.2%
95.2%
84.6%
68.9%f such a strategy was earlier established clinically with temporary
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February 7, 2012:630–3Figure 1 12-Lead Summary and Leads Recorded by an Implanted Electrode During Exercise
(A) 12-lead summary during exercise. (B) Leads recorded by the implanted electrode by the Angel Med system during exercise.
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February 7, 2012:630–3balloon occlusion during a coronary intervention procedure (2), and
experimentally with acute or subacute coronary occlusion in ambula-
tory porcine models (3). We present an anecdotal case that under-
cores superior efficacy of an intracardiac electrocardiogram.
A 54-year-old woman had an anterior myocardial infarction
n 2007, followed by coronary bypass surgery wherein com-
letely occluded left anterior descending coronary artery and
ircumflex vessels were revascularized. She continued to com-
lain of angina symptoms, and a repeat angiogram in 2008
howed 40% narrowing of the graft to the left anterior descend-
ng artery. In December 2009, she developed chest pain during
treadmill stress test at a heart rate of 120 beats/min with
quivocal ECG changes. She participated in the ALERTS
AngelMed for Early Recognition and Treatment of STEMI)
linical study (NCT00781118), and received an intracardiac isch-
mia detection device with an electrocardiographic (ECG) lead placed
n the right ventricular apex. The study protocol calls for a stress test
weeks after implantation. During the dobutamine stress test, her
eart rate increased from 54 to 126 beats/min, and the test was
erminated because of chest discomfort. The rest and maximum stress
urface ECG strips (Fig. 1A) revealed minor J-point depression and
ere considered nondiagnostic. The simultaneously recorded ECG
rom the implanted device (Fig. 1B) demonstrated substantial ST-
egment depression.
This case highlights 2 points. 1) Leads recorded from the
ndocardium are probably more sensitive than standard leads. In
xperimental simulations, subendocardial ischemia that extended
hrough at least 40% of the heart wall was manifest on the
picardium by ST-segment depression. As such, the lesser extent
f ischemia may have resulted in the discrepancy between surface
nd intracardiac ECGs. 2) A minor upsloping ST-segment de-
ression during exercise testing may not always be benign. Al-
hough the Joint Committee on Exercise Testing also describesJ-point depression as normal, we should carefully analyze ECG
alterations that accompany stress tests (4).
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